(S)-4-Methyl-2-(methylamino)pentanoic acid, 95.0%, 100g

(R)-Octahydropyrazino[2,1-c][1,4]oxazine dihydrochloride, 95.0%, 5g

FMOC-d-4-Fluorophenylalanine, 97.0%, 1g

1,3-Diaminotetrafluorobenzene, 99.0%, 250mg

2-Cyano-4-methyl-5-nitropyridine, 95.0%, 25g

2-(4,5-Dihydrofuran-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g

2-BOC-2-AZASPIRO[3.5]NONANE-7-METHAMINE, 95.0%, 1g

1-(4-Chlorobenzyl)-6-(ethylthio)-1,3,5-triazine-2,4(1H,3H)-dione, 97%, 250mg

5'-?O-?[Bis(4-?methoxyphenyl)phenylmethyl]?-2'-?O-methyl-?N-(2-?methyl-?1-?oxopropyl)guanosine, 97%, 5g

Sample vials ROTILABO®, Clear glass, 5 ml, 100 Piece(s)

p-Tolunitrile>98.0%(GC)500g

Ethyl 2-((cyclopropylmethoxy)amino)benzoate, 97%, 25g

1,2-Bis(chlorodimethylsilyl)ethane [Protecting Reagent for Primary Amines]>95.0%(GC)25g